Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
vTv Therapeutics (VTVT)
NASDAQ:VTVT
vTv Therapeutics (VTVT) Stock Price & Analysis
711 Followers
VTVT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.41 - $1.05
Previous Close$0.43
Volume48.83K
Average Volume (3M)169.93K
Market Cap
$34.95M
Enterprise ValueN/A
Total Cash (Recent Filing)$12.60M
Total Debt (Recent Filing)$417.00K
Price to Earnings (P/E)-1.8
Beta1.37
Next Earnings
Nov 09, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding104,577,460
10 Day Avg. Volume43,875
30 Day Avg. Volume169,928
Standard Deviation0.38
R-Squared0.03
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)-1.93
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
vTv Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VTVT FAQ
What was vTv Therapeutics’s price range in the past 12 months?
vTv Therapeutics lowest stock price was $0.41 and its highest was $1.05 in the past 12 months.
What is vTv Therapeutics’s market cap?
Currently, no data Available
When is vTv Therapeutics’s upcoming earnings report date?
vTv Therapeutics’s upcoming earnings report date is Nov 09, 2023 which is in 47 days.
How were vTv Therapeutics’s earnings last quarter?
vTv Therapeutics released its earnings results on Aug 11, 2023. The company reported -$0.07 earnings per share for the quarter, the consensus estimate of -$0.07 by $0.
Is vTv Therapeutics overvalued?
According to Wall Street analysts vTv Therapeutics’s price is currently Overvalued.
Does vTv Therapeutics pay dividends?
vTv Therapeutics does not currently pay dividends.
What is vTv Therapeutics’s EPS estimate?
vTv Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does vTv Therapeutics have?
vTv Therapeutics has 81,483,600 shares outstanding.
What happened to vTv Therapeutics’s price movement after its last earnings report?
vTv Therapeutics reported an EPS of -$0.07 in its last earnings report, expectations of -$0.07. Following the earnings report the stock price went up 2.778%.
Which hedge fund is a major shareholder of vTv Therapeutics?
Currently, no hedge funds are holding shares in VTVT
---
vTv Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
VTVT Sentiment 100%
Sector Average 67%
Sector Average 67%
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.5%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.03%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-39.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
vTv Therapeutics
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
---
Top 5 ETFs holding VTVT
Vanguard Total Stock Market ETF
$318.77K
iShares Core S&P Total U.S. Stock Market ETF
$3.83K
Up to five ETFs with an Outperform Smart Score that hold VTVT. The ETFs are listed according to market value of VTVT within the ETF
---